Northern, WI 7/ 23/ 2012 (TheStreetBeat) -- Galectin Therapeutics (NASD:GALT): has been issued a new patent in their ongoing treatment of liver disease. This has sent their share price up over 70% in morning trading.
Full Disclaimer HereDistributed by Viestly
No comments:
Post a Comment